The COVID-19 pandemic is currently top of mind among pharma professionals, but stakeholders have other business to attend to – such as the upcoming deadline to meet regulatory requirements of the US FDA’s 2013 Drug Supply Chain Security Act.
Peter Sturtevant
Advertisement
Articles by Peter Sturtevant
A new assessment shows year-over-year improvements on meeting DSCSA serialization requirements, which indicate the industry is making steady progress.
Despite delay in enforcement of Drug Supply Chain Security Act's new serialization requirement, getting compliant now is key.
Advertisement
Latest Updated Articles
Drug Serialization for DSCSA Compliance Benefits EveryonePublished: September 21st 2017 | Updated:
- Serialization and Interoperability–Meeting the Goals of DSCSA
Published: December 2nd 2019 | Updated:
Key Regulatory Deadlines Loom for Drug Dispensers and WholesalersPublished: May 20th 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
2
FDA Announces New Biosimilar-Targeted Draft Guidance
3
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
4
Lilly Forms Partnership with NVIDIA to Create AI Supercomputer
5
